Equities

Narayana Hrudayalaya Ltd

Narayana Hrudayalaya Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)1,237.30
  • Today's Change10.75 / 0.88%
  • Shares traded302.27k
  • 1 Year change+25.53%
  • Beta0.8702
Data delayed at least 15 minutes, as of Jun 14 2024 10:57 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Narayana Hrudayalaya Limited is an India-based healthcare service provider, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The Company is primarily engaged in the business of rendering medical and healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations. The Company owns and operates certain hospitals. Its medical services include anesthesia, blood bank, bone marrow transplant (stem cell transplant), breast cancer, electrophysiology, emergency medicine, endocrinology, family medicine, gastrointestinal oncology, general surgery, geriatrics, gynecology - oncology, pulmonology, radiation oncology, hematology, heart transplant, hepatology liver transplantation and infectious diseases. The Company has a network of approximately 19 hospitals and three heart centers across India along with overseas presence at Cayman Islands, with over 5,860 operational beds and a capacity of over 6,160 beds.

  • Revenue in INR (TTM)50.22bn
  • Net income in INR7.89bn
  • Incorporated2000
  • Employees11.73k
  • Location
    Narayana Hrudayalaya Ltd2nd Floor, No. 261/ABommasandra Industrial Area, Hosur RoadAnekal ThalukBANGALORE 560099IndiaIND
  • Phone+91 8 071222222
  • Fax+91 8 071222611
  • Websitehttps://www.narayanahealth.org/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Healthcare Global Enterprises Ltd19.08bn481.40m54.50bn5.50k114.076.6025.272.863.433.43136.1259.290.759621.966.40--1.65-2.262.26-3.0553.4053.782.17-3.500.85681.390.5956--12.8014.3564.03--0.0453--
Jupiter Life Line Hospitals Ltd10.70bn1.77bn81.31bn3.14k43.296.9637.137.6028.6528.65171.06178.300.94369.3920.79--15.58--17.39--82.28--16.51--3.677.430.00--19.83--142.25------
Vijaya Diagnostic Centre Ltd5.48bn1.19bn81.35bn2.00k68.4612.3646.0514.8511.5911.5953.4464.210.596718.1042.58--13.0314.1014.1415.5488.0586.4121.8421.202.836.830.2826.6619.3413.3740.4020.977.58--
Metropolis Healthcare Ltd12.08bn1.28bn100.32bn4.29k78.719.1545.008.3124.8824.88235.10213.970.79026.159.73--8.4013.6510.1116.9478.7975.7310.6414.661.138.350.152--5.189.67-10.541.2521.84--
Rainbow Children's Medicare Ltd12.97bn2.17bn132.96bn3.58k61.2710.5640.2510.2521.3821.38127.78124.030.65817.7321.29--11.089.8911.9910.9687.2683.5116.8313.804.005.360.377--10.5119.032.9337.2332.22--
Krishna Institute Of Medical Sciencs Ltd24.98bn3.10bn162.99bn10.00k52.558.9133.776.5238.7638.76312.20228.460.735511.499.13--9.9013.7112.2016.7378.7761.4213.4615.531.1010.440.393--13.6722.17-7.78--52.94--
Aster DM Healthcare Ltd84.60bn293.50m178.25bn24.65k609.613.9128.742.110.58742.60170.4891.600.51474.816.58--0.67922.241.393.6059.7860.171.324.261.251.870.2157--23.54-14.2212.28-18.156.87--
Dr. Lal PathLabs Ltd22.27bn3.58bn228.86bn4.10k63.9912.3845.2410.2842.9842.98267.51222.230.919812.7030.045,432,157.0014.9715.4918.8819.3879.7376.1316.2715.992.3415.860.115823.8610.4013.1049.7812.436.4431.95
Narayana Hrudayalaya Ltd50.22bn7.89bn251.30bn11.73k31.838.7124.365.0038.8738.87247.31141.981.0321.5811.77--16.1410.7920.5513.9761.0049.8315.729.721.659.390.3605--10.9111.8930.1967.8945.2731.95
Fortis Healthcare Ltd68.93bn5.99bn379.18bn2.98k63.344.9538.395.507.937.9391.26101.500.53614.0611.40--5.023.546.664.5776.5273.879.367.630.41427.620.1189--9.459.051.72--62.52--
Abbott India Ltd58.49bn12.01bn583.61bn3.70k48.5915.7845.879.98565.28565.282,752.431,740.711.205.0818.39--24.6420.9233.3728.5944.9444.3220.5417.261.96111.000.02248.299.359.7226.5221.6831.0852.32
Data as of Jun 14 2024. Currency figures normalised to Narayana Hrudayalaya Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

12.57%Per cent of shares held by top holders
HolderShares% Held
Axis Asset Management Co. Ltd.as of 30 Jun 20239.94m4.86%
DSP Asset Managers Pvt. Ltd.as of 31 May 20243.26m1.60%
The Vanguard Group, Inc.as of 06 Jun 20242.81m1.38%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 May 20242.42m1.18%
Franklin Templeton Asset Management (India) Pvt Ltd.as of 30 Apr 20241.46m0.71%
Templeton Asset Management Ltd.as of 31 Mar 20241.46m0.71%
PGIM India Asset Management Pvt Ltd.as of 31 May 20241.18m0.58%
ICICI Prudential Life Insurance Co. Ltd. (Invt Port)as of 31 May 20241.15m0.56%
BlackRock Fund Advisorsas of 06 Jun 20241.08m0.53%
Wellington Management Singapore Pte Ltd.as of 30 Jun 2023934.85k0.46%
More ▼
Data from 31 Mar 2024 - 13 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.